Eri Matsubara
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A lung squamous cell carcinoma demonstrating spontaneous partial regression of the primary tumor with lymph node metastasis: a case report with analysis of the tumor immune microenvironment.
Journal: Translational lung cancer research
Published: December 20, 2025
Integrative analysis of T cell subset-specific ICOS expression and tumor HLA class I/II expression in lung adenocarcinoma: implications for their interaction and clinical outcome.
Journal: Cancer immunology, immunotherapy : CII
Published: December 03, 2025
Volatile Essential Oils from Different Tree Species Influence Scent Impression and Physiological Response.
Journal: Molecules (Basel, Switzerland)
Published: June 30, 2025
NUF2 Expression in Cancer Tissues and Lymph Nodes Suggests Post-Surgery Recurrence of Non-Small Cell Lung Cancer.
Journal: Diagnostics (Basel, Switzerland)
Published: January 12, 2024
IL-32 production from lung adenocarcinoma cells is potentially involved in immunosuppressive microenvironment.
Journal: Medical molecular morphology
Published: October 23, 2023
PD-L2 overexpression on tumor-associated macrophages is one of the predictors for better prognosis in lung adenocarcinoma.
Journal: Medical molecular morphology
Published: May 18, 2023
The expression of PD-1 ligand 1 on macrophages and its clinical impacts and mechanisms in lung adenocarcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: November 07, 2021
CD163-positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma.
Journal: Pathology international
Published: April 26, 2021
Last Updated: 09/26/2026